On the News
Innovative Development – Meet Scentech-Medical – Disease and Pathogen Detection in Breath
NextGen to start “Coronavirus Breathalyzer” tests; Projections: $100 million in 2021 revenue
NextGen Biomed trial brings Covid-19 breath test nearer
New development: a breathalyzer that detects whether you have the Coronavirus
Israel Export Institute – Yaniv Chevron, Scentech-Medical CEO, discusses the new standard we will all have to get used to: “Biological Security”